Drug details

Incruse Ellipta (umeclidinium inhalation powder)

type of Anticholinergics, Respiratory

Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• wheezing,
• vision changes,
• severe dizziness
• eye pain or swelling,
• seeing halos around lights,
• blurred vision, and
• redness of the eye,
• difficult or painful urination,

The following drugs are related to Incruse Ellipta, either as a replacement or used together:

• Tudorza Pressair (aclidinium bromide)
• Atrovent HFA (ipratropium bromide inhalation aerosol)
• Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
• Symbicort Aerosphere (budesonide and formoterol fumarate inhalation aerosol)
• Combivent (ipratropium bromide and albuterol sulfate)
• Combivent Respimat (ipratropium bromide and albuterol)
• Daliresp (roflumilast)
• Striverdi Respimat (olodaterol inhalation spray)
• Yupelri (revefenacin inhalation solution)
• Spiriva (tiotropium bromide)
• Spiriva Respimat (tiotropium bromide inhalation spray)
• Tezspire (tezepelumab-ekko injection, for subcutaneous use)